1 year return (CAGR)
12.89%
Gefran S.p.A Exchange (MI, EUR)
GE.MI
-
-0.05 (-0.49%)
TechnologyElectronic Components
Loading...
3 year return (CAGR)
1.51%
5 year return (CAGR)
11.12%
10 year return (CAGR)
20.68%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
145.57M
Price/Sales
1.07
Ent value
154.74M
Price/Book
1.45
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
14.82
PEG
-
Forward P/E
-
EPS growth
9.87%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 10.30 |
| Daily high | 10.55 |
| Daily low | 10.25 |
| Daily Volume | 5K |
| 1y analyst estimate | 13.20 |
| Beta | 1.07 |
| EPS (TTM) | 0.69 |
| Dividend per share | 0.00 |
| Ex-div date | 5 May 2025 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| GE.MI | S&P500 | |
| Current price drop from All-time high | -99.91% | -0.89% |
| Highest price drop | -99.99% | -56.47% |
| Date of highest drop | 12 Feb 2016 | 9 Mar 2009 |
| Avg drop from high | -98.48% | -10.67% |
| Avg time to new high | 3505 days | 12 days |
| Max time to new high | 7009 days | 1805 days |
News
Ramsay Générale de Santé has spent the past few years under pressure, yet the shares have climbed modestly over the past year, which puts a fresh spotlight on what investors are paying for its sales t...
October 10, 2026
Ramsay Générale de Santé (ENXTPA:GDS) has called a board meeting for 6 October 2026 to review the auditors’ certification report on its consolidated accounts, a routine governance step that remains im...
October 10, 2026
Melexis has delivered a mixed share price record over recent years, which raises a direct question for anyone looking at the stock today. Is the current market valuation really supported by the cash f...
October 9, 2026
Oncology stocks are gaining relevance as cancer care evolves, with Pfizer, Merit Medical Systems and Abbott advancing treatments, diagnostics and screening technologies.
October 9, 2026
Suominen Corporation’s stock exchange release on October 9, 2026, at 11:00 a.m. (EEST) Suominen Corporation will publish its financial reports in 2027 as follows: March 2, 2027 – Financial Statements ...
October 9, 2026
Investing.com -- Barclays downgraded Ryanair and Norwegian Air Shuttle to Equal Weight from Overweight, saying persistently high fuel prices threaten fourth-quarter and 2027 profits across European ai...
October 9, 2026
Argenx unexpectedly scrapped a study of its drug, Vyvgart, in patients with Sjogren's disease on Thursday. The stock plummeted in response.
October 8, 2026
Argenx says it discontinued a late-stage clinical trial in patients with Sjögren’s disease at the recommendation of an independent committee.
October 8, 2026
INFORMATION REGARDING THE TOTAL VOTING RIGHTS AND SHARES OF KLÉPIERRE SA AS OF SEPTEMBER 30, 20261 Paris – October 8, 2026 NUMBER OF SHARES AS OF SEPTEMBER 30, 2026 Date09/30/2026Company nameKlépierre...
October 8, 2026